Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

Bile Acid Receptor Antibodies

Close filters
No results were found for the filter!
NEW
Validation of the GPBA Receptor in transfected HEK293 cells.
GPBA (non-phospho), Bile Acid Receptor Antibody
The non-phospho-GPBA receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPBA. It can be used to detect total GPBA receptors in Western blots independent of phosphorylation. The GPBA antibody can...
£ 335.00 *
Details

 

The apelin receptor (APLNR) responds to apelin, a 36 amino-acid peptide which is cleaved from a 77 amino-acid precursor peptide. Apelin-36, apelin-13 and [Pyr1]apelin-13 are the predominant endogenous ligands. A second family of peptides named Elabela/Toddler has discovered independently as endogenous ligands. The apelin receptor is coupled to inhibitory G-proteins. A number of physiological roles for the receptor have emerged, including regulation of cardiovascular function, fluid homeostasis, the adipoinsular axis, gastrointestinal and immunomodulatory functions. APLNR receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine343/serine345 (pS343/pS345-APLNR) and serine347/serine348 (pS347/pS348-APLNR). This nomenclature refers to human APLNR. This phosphorylation motif is highly conserved across species but corresponds to pS341/pS343-APLNR and pS345/pS346-APLNR in mice and rats. For more information on APLNR pharmacology please refer to the IUPHAR database. For further reading refer to:

Pitkin SL, Maguire JJ, Bonner TI, Davenport AP. International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function. Pharmacol Rev. 2010 Sep;62(3):331-42. doi: 10.1124/pr.110.002949. Epub 2010 Jul 6. PMID: 20605969.

  The apelin receptor (APLNR) responds to apelin, a 36 amino-acid peptide which is cleaved from a 77 amino-acid precursor peptide. Apelin-36, apelin-13 and [Pyr1]apelin-13 are the... read more »
Close window
Bile Acid Receptor Antibodies

 

The apelin receptor (APLNR) responds to apelin, a 36 amino-acid peptide which is cleaved from a 77 amino-acid precursor peptide. Apelin-36, apelin-13 and [Pyr1]apelin-13 are the predominant endogenous ligands. A second family of peptides named Elabela/Toddler has discovered independently as endogenous ligands. The apelin receptor is coupled to inhibitory G-proteins. A number of physiological roles for the receptor have emerged, including regulation of cardiovascular function, fluid homeostasis, the adipoinsular axis, gastrointestinal and immunomodulatory functions. APLNR receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine343/serine345 (pS343/pS345-APLNR) and serine347/serine348 (pS347/pS348-APLNR). This nomenclature refers to human APLNR. This phosphorylation motif is highly conserved across species but corresponds to pS341/pS343-APLNR and pS345/pS346-APLNR in mice and rats. For more information on APLNR pharmacology please refer to the IUPHAR database. For further reading refer to:

Pitkin SL, Maguire JJ, Bonner TI, Davenport AP. International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function. Pharmacol Rev. 2010 Sep;62(3):331-42. doi: 10.1124/pr.110.002949. Epub 2010 Jul 6. PMID: 20605969.

Recently viewed